Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke
Open Access
- 1 November 2024
- journal article
- research article
- Published by KEAI Publishing in Genes & Diseases
- Vol. 11 (6) , 101262
Abstract
Programmed cell death contributes to neurological damage in ischemic stroke, especially during the reperfusion stage. Several cell death pathways have been tested preclinically and clinically, including ferroptosis, necroptosis, and apoptosis. However, the sequence and complex interplay between cell death pathways during ischemia/reperfusion remains under investigation. Here, we unbiasedly investigated cell death pathways during ischemia/reperfusion by utilizing RNA sequencing analysis and immunoblot assays and revealed that ferroptosis and necroptosis occurred early post-reperfusion, followed by apoptosis. Ferroptosis inhibitor Liproxstatin-1 effectively inhibited necroptosis during reperfusion, while the necroptosis inhibitor Necrostatin-1 suppressed protein expression consistent with ferroptosis activation. Protein-protein interaction analysis and iron chelation therapy by deferoxamine mesylate indicate that iron is capable of promoting both ferroptosis and necroptosis in middle cerebral artery occlusion/repression modeled mice. Treatment of cells with iron led to a disruption in redox balance with activated necroptosis and increased susceptibility to ferroptosis. Collectively, these data uncovered a complex interplay between ferroptosis and necroptosis during ischemic stroke and indicated that multiple programmed cell death pathways may be targeted co-currently.Keywords
Funding Information
- Sichuan University West China hospital
- Fundamental Research Funds for the Central Universities
- Ministry of Science and Technology of the People's Republic of China
- Science and Technology Department of Sichuan Province
This publication has 61 references indexed in Scilit:
- Inhibition of ACSL4 Alleviates Parkinsonism Phenotypes by Reduction of Lipid Reactive Oxygen SpeciesNeurotherapeutics, 2023
- An in vitro evaluation of the antioxidant activities of necroptosis and apoptosis inhibitors: the potential of necrostatin-1 and necrostatin-1i to have radical scavenging activitiesPharmacological Reports, 2023
- Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseasesAgeing Research Reviews, 2023
- MiR-20a-5p alleviates kidney ischemia/reperfusion injury by targeting ACSL4-dependent ferroptosisAmerican Journal of Transplantation, 2023
- Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implicationsMedicinal Research Reviews, 2021
- The Key Regulator of Necroptosis, RIP1 Kinase, Contributes to the Formation of Astrogliosis and Glial Scar in Ischemic StrokeTranslational Stroke Research, 2021
- The Impact of SARS‐CoV‐2 on Stroke Epidemiology and Care: A Meta‐AnalysisAnnals of Neurology, 2020
- Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With InfluenzaJAMA Neurology, 2020
- Combination of Emricasan with Ponatinib Synergistically Reduces Ischemia/Reperfusion Injury in Rat Brain Through Simultaneous Prevention of Apoptosis and NecroptosisTranslational Stroke Research, 2017
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced InflammationCell, 2009